Notice of Intent to Publish a Funding Opportunity Announcement for FDA Drug Residue Cooperative Agreement (U18)

Notice Number: NOT-FD-16-005

Key Dates
Release Date:   March 3, 2016
Estimated Publication Date of Announcement:  March 2016   
First Estimated Application Due Date:  May 2016 
Earliest Estimated Award Date:  September 2016 
Earliest Estimated Start Date:  September 2016 

Related Announcements
None    

Issued by
U.S. Food and Drug Administration (FDA)

Purpose

The U.S. Food and Drug Administration, Office of Regulatory Affairs, intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications for cooperative agreements to advance efforts to improve and develop state drug residue prevention programs.  The FDA intends to provide assistance to promote the prevention of illegal drug residues in animal derived foods and to protect consumer exposure to drug residues in the edible products of food animals.

The proposed objective of FDA’s ORA cooperative agreement program is to develop, complement and enhance state drug residue prevention programs through educational outreach and training activities.  Related activities may include and are not limited to the following:   

  • develop materials needed to promote the prevention of illegal drug residues in animal derived foods
  • communicate and promote effective management practices for drug residue prevention
  • increase the knowledge of and compliance with approved drug use
  • extralabel drug use regulations and its prohibitions
  • understanding of treated animal management
  • measuring the performance of existing state drug residue prevention program
  • identifying areas of improvement and/or developing new programs
  • reduce the outcomes of illegal drug residues in animal derived foods
  • protect consumer exposure to drug residues in the edible products of food animals

This proposed opportunity may potentially be available to state government agencies that have current FDA tissue residue inspection contracts or have previously been awarded an FDA tissue residue inspection contract. 

This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. 

The FOA is expected to be published in March 2016 with an expected application due date in May 2016.

APPLICATIONS ARE NOT BEING SOLICITED AT THIS TIME.

Inquiries

Please direct all inquiries to:

Daniel Lukash
Email: daniel.lukash@fda.hhs.gov  

NIH Office of Extramural Research Logo
Department of Health and Human Services (HHS) - Home Page
Department of Health
and Human Services (HHS)
USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.